These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10343039)

  • 41. American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction.
    Termini RB; Tressler L
    Food Drug Law J; 2008; 63(1):257-74. PubMed ID: 18561461
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 43. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies.
    Dudzinski DM
    Food Drug Law J; 2005; 60(2):143-260. PubMed ID: 16094771
    [No Abstract]   [Full Text] [Related]  

  • 44. The congressional polio vaccine hearings of 1955. A landmark in biomedial research.
    Williamson S
    Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(2):13-21. PubMed ID: 18686535
    [No Abstract]   [Full Text] [Related]  

  • 45. Biologicals: new horizons in pharmaceutical development.
    Oldham RK
    J Biol Response Mod; 1983; 2(3):199-206. PubMed ID: 6358418
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmaceuticals issue brief: medical marijuana: year end report-2002.
    Herstek J; Watson A; Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-12. PubMed ID: 12856685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perceived "War on Doctors" nearing 100 years: part I (1914-2000).
    Sanbar SS
    J Okla State Med Assoc; 2011 Sep; 104(9):357-60. PubMed ID: 22164576
    [No Abstract]   [Full Text] [Related]  

  • 48. Animal health and consumer protection.
    Bren L
    FDA Consum; 2006; 40(1):42-9. PubMed ID: 16528827
    [No Abstract]   [Full Text] [Related]  

  • 49. Report of the Task Force on the future of OTC drugs.
    Collins DE
    Food Drug Law J; 2000; 55(1):27-31. PubMed ID: 12269359
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug regulation 2056.
    Bezold C; Peck J
    Food Drug Law J; 2005; 60(2):127-36. PubMed ID: 16097091
    [No Abstract]   [Full Text] [Related]  

  • 51. [The international control of narcotics during the past 40 years].
    Vaille C
    Presse Med (1893); 1968 Apr; 76(19):939-41. PubMed ID: 4868842
    [No Abstract]   [Full Text] [Related]  

  • 52. [The industrialisation of therapeutic agents: a story of practices between science, technology, medicine and the law].
    Gaudillière JP
    Gesnerus; 2007; 64(1-2):93-108. PubMed ID: 17982961
    [No Abstract]   [Full Text] [Related]  

  • 53. Making sure biologicals are safe.
    Hecht A
    FDA Consum; 1977; 11(6):21-6. PubMed ID: 10304996
    [No Abstract]   [Full Text] [Related]  

  • 54. Overview of the Hatch-Waxman Act and its impact on the drug development process.
    Mossinghoff GJ
    Food Drug Law J; 1999; 54(2):187-94. PubMed ID: 11758572
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmaceuticals: generic/ therapeutic drug substitution: year end report-2002.
    Floridi T; Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-12. PubMed ID: 12856672
    [No Abstract]   [Full Text] [Related]  

  • 56. From Slaughter-House to Lochner: the rise and fall of the constitutionalization of public health.
    Parmet WE
    Am J Leg Hist; 1996; 40():476-505. PubMed ID: 12568072
    [No Abstract]   [Full Text] [Related]  

  • 57. [40 years of regulation and control by the drug service in the German Democratic Republic].
    Richter J; Wolski M
    Pharmazie; 1989 Oct; 44(10):666-71. PubMed ID: 2694183
    [No Abstract]   [Full Text] [Related]  

  • 58. The advancement of controlled clinical trials.
    Bren L
    FDA Consum; 2007; 41(2):23-30. PubMed ID: 17582863
    [No Abstract]   [Full Text] [Related]  

  • 59. The pharmaceutical industry and legislation in Egypt--historical perspectives and current practice.
    Kandil A
    J Clin Pharm Ther; 1989 Apr; 14(2):83-5. PubMed ID: 2656730
    [No Abstract]   [Full Text] [Related]  

  • 60. Plants as intellectual property: American practice, law, and policy in world context.
    Bugos GE; Kevles DJ
    Osiris; 1992; 7():75-104. PubMed ID: 11615252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.